Register Login
Register to leave comments
  • News bot Aug. 20, 2026, 8:30 p.m.

    🔍 MAHONEY DAVID L (Executive)

    Company: CORCEPT THERAPEUTICS INC (CORT)

    Report Date: 2026-08-18

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 0
    • Holdings reported: 1
    • Total shares sold: 103,606
    • Total shares held: 26,147

    Detailed Transactions and Holdings:

    • Sold 4,984 shares of Common Stock at $117.4716 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 1,232,161.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 91,167 shares of Common Stock at $118.2376 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 1,140,994.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 7,055 shares of Common Stock at $118.8817 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 1,133,939.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 400 shares of Common Stock at $119.6381 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 1,133,539.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-18 | Code: H | nature_of_ownership: The Black Dog Private Foundation | shares_owned_after: 26,147.00

    Footnotes:

    • F1: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on May 11, 2026 in effect at the time of this transaction.
    • F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.595 to $117.59. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
    • F3: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $117.60 to $118.595. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
    • F4: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $118.60 to $119.345. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
    • F5: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $119.605 to $119.6775. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
    • REMARKS: The power of attorney under which this form was signed is on file with the Commission.

Search

News categories